North America Starch Softgel Capsules Market Growth and Forecast by 2027

Historic Data: 2017-2018   |   Base Year: 2019   |   Forecast Period: 2020-2027

North America Starch Softgel Capsules Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application (Pharmaceutical, Health Supplements, Others); Distribution Channel (Supermarket and Hypermarket, Pharmacy and Drugstore, Online Provider)

  • Report Date : Aug 2020
  • Report Code : TIPRE00013023
  • Category : Life Sciences
  • Status : Published
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 134
Page Updated: Oct 2020

The North America starch softgel capsules market is expected to reach US$ 202.54 million by 2027 from US$ 139.13 million in 2019. The market is estimated to grow at a CAGR of 4.9% from 2020 to 2027.



The growth of the market is attributed to increasing availability of vegetarian softgel capsules, and rising preference of pharmaceutical and nutraceutical companies toward softgel capsules. However, difficulties in optimizing cellulose/starch for API delivery hinders the growth of the market in North America.

The North America Starch Softgel Capsules market is expected to witness significant growth during the forecast period due to rising prevalence of chronic diseases and demand of health supplements for the management of these diseases is boosting the growth of the market. Additionally, presence of a large number of manufacturers engaged in the manufacturing of starch based softgel capsules are further driving the growth of the market in the country. For instance, Grain Processing Corporation offers PURE-COTE modified starches that are used with other film-forming polymers to produce non-gelatin, softgel capsules. Moreover, the market of health-conscious consumers seeking plant-based products is booming, further driving the demand of starch softgel capsules in nutraceutical.

The US is among the major countries in the starch softgel capsules market in this region. The growth of market is prominently attributed to a rising consumption of health supplements. For instance, as per the Council for Responsible Nutrition (CRN) 2019 survey, currently, approximately 72% of people are taking at least one nutraceutical supplement in the US.

North America Starch Softgel Capsules Market Revenue and Forecast to 2027 (US$ Million)

North America Starch Softgel Capsules Market Revenue and Forecast to 2027 (US$ Million)
  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Starch Softgel Capsules Market Segmentation

By Application

  • Pharmaceutical
  • Health Supplements
  • Others

By Distribution Channel

  • Supermarket and Hypermarket
  • Pharmacy and Drugstore
  • Online Provider

By Country

  • US
  • Canada
  • Mexico

Company Profiles

  • Catalent Inc
  • Robinson Pharma, Inc
  • ProCaps
  • CAPTEK Softgel International Inc
  • Sirio Pharma Co

North America Starch Softgel Capsules Report Scope

Report Attribute Details
Market size in 2019 US$ 139.13 Million
Market Size by 2027 US$ 202.54 Million
CAGR (2020 - 2027)4.9%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Application
  • Pharmaceutical
  • Health Supplements
By Distribution Channel
  • Supermarket and Hypermarket
  • Pharmacy and Drugstore
  • Online Provider
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Catalent Inc
  • Robinson Pharma, Inc
  • ProCaps
  • CAPTEK Softgel International Inc
  • Sirio Pharma Co
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Our Clients
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
Email: sales@theinsightpartners.com
Chat with us
DUNS Logo
87-673-9708
ISO Certified Logo
ISO 9001:2015
ISO Certified Logo